ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 2 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $40,056,000 | +60.6% | 6,642,814 | -4.1% | 13.12% | +31.6% |
| Q3 2019 | $24,947,000 | +34.3% | 6,929,653 | 0.0% | 9.97% | +13.2% |
| Q2 2019 | $18,571,000 | -9.5% | 6,929,653 | 0.0% | 8.81% | -20.3% |
| Q1 2019 | $20,512,000 | +148.5% | 6,929,653 | +33.5% | 11.06% | +147.3% |
| Q4 2018 | $8,255,000 | +15.3% | 5,191,600 | +166.8% | 4.47% | +90.8% |
| Q3 2018 | $7,162,000 | – | 1,946,107 | – | 2.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |